Welcome to our dedicated page for Alignment Healthcare news (Ticker: ALHC), a resource for investors and traders seeking the latest updates and insights on Alignment Healthcare stock.
Alignment Healthcare, Inc. reports developments tied to its Medicare Advantage business for seniors, including health plan membership, revenue growth, adjusted gross profit, adjusted EBITDA and annual guidance. The company operates under the Alignment Health consumer brand and works with local provider partners to deliver coordinated care through a customized care model, a 24/7 concierge care team and the AVA® technology platform.
Recurring updates include quarterly and full-year results, membership outlooks for HMO and PPO contracts, Medicare Advantage operating trends, investor conference presentations and registered offerings involving common stock. News also follows the company's expansion of health plan offerings and national footprint within senior care.
Alignment Healthcare (NASDAQ: ALHC) announced an underwritten public offering on March 2, 2026, of 13,167,733 shares of common stock by an affiliate of General Atlantic, L.P.
The company will not receive any proceeds; J.P. Morgan is acting as underwriter and the offering is made under a Form S-3 shelf registration that became effective March 2, 2026.
Alignment Healthcare (NASDAQ: ALHC) reported strong fourth-quarter and full‑year 2025 results, with full‑year revenue of $3.95B (+46.1% YoY) and Q4 revenue of $1,012.8M (+44.4% YoY). Health plan membership ended Q4 at ~236,300 (+25% YoY).
The company posted full‑year adjusted EBITDA of $109.9M and net loss of $1.0M, and raised 2026 guidance to revenue $5.14B–$5.19B (30%–31% growth) and adjusted EBITDA $133M–$163M.
Alignment Healthcare (NASDAQ: ALHC) will present at the Leerink Partners Global Healthcare Conference in Miami on Tuesday, March 10, 2026 at 3:40 p.m. EST. A live webcast and on-demand replay will be available on Alignment’s investor relations website.
Alignment Healthcare (NASDAQ: ALHC) will release fourth-quarter and full-year 2025 financial results on Thursday, Feb. 26, 2026 after market close, followed by a conference call at 5:00 p.m. EST. A live audio webcast will be available and a replay will remain online for approximately 12 months.
Alignment Healthcare (NASDAQ: ALHC) was named to the 2026 Fortune World’s Most Admired Companies list, debuting in its first year of eligibility on Jan. 21, 2026.
The recognition reflects peer ratings in the Health Care: Insurance and Managed Care category and cites leadership, innovation, and operating ability. Alignment highlighted its AVA® technology platform and multiple 2025 quality recognitions, including 100% of members enrolled in plans rated 4+ stars and 5-star HMO contracts in Nevada and North Carolina.
Alignment Health (NASDAQ: ALHC) appointed Adnan Mansour as chief digital officer, effective Jan. 19, 2026, to unify technology and information functions and accelerate AI-driven growth. Mansour reports to founder and CEO John Kao and will scale the company’s digital capabilities and its AI-powered AVA® platform. Alignment reported Jan. 1 membership of approximately 275,300, representing 31% year-over-year growth. Mansour previously led Optum Insight’s global payer technology organization overseeing 2,000+ engineers and 300+ applications, launched 20+ production AI applications at Change Healthcare, and holds multiple U.S. patents.
Alignment Healthcare (NASDAQ: ALHC) reported Jan. 1, 2026 health plan membership of approximately 275,300, a 31% year-over-year increase after a strong AEP and a ~30% compounded annual membership growth since its 2021 IPO. The company guides year-end 2026 membership of 290,000 to 296,000 (about 24%–27% growth vs. the midpoint of prior guidance) and expects consensus adjusted EBITDA ≈ $145 million for 2026 to fall within its full-year guidance range. The company reaffirmed its full-year 2025 guidance for membership, revenue, adjusted gross profit and adjusted EBITDA and noted timing for full 2026 guidance at its Q4 2025 earnings call.
Alignment Healthcare (NASDAQ: ALHC) will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 14, 2026 at 10:30 a.m. PST. A live webcast and on-demand replay will be available on Alignment Healthcare's investor relations website.
Investors can view the presentation via the company webcast at https://ir.alignmenthealth.com/.
Alignment Healthcare (NASDAQ: ALHC) will present at the Piper Sandler 37th Annual Healthcare Conference in New York on Wednesday, Dec. 3, 2025 at 10:00 a.m. EST.
A live webcast and replay will be available on Alignment Healthcare’s investor relations website at https://ir.alignmenthealth.com/.
Alignment Healthcare (NASDAQ: ALHC) reported third quarter 2025 results and exceeded the high end of guidance across all key metrics on Oct 30, 2025. Q3 revenue was $993.7M (+43.5% YoY) and health plan membership reached ~229,600 (+25.9% YoY). Adjusted gross profit was $127.5M, adjusted EBITDA was $32.4M, and net income was $3.7M. The company said 100% of members are in plans rated 4 stars or higher for the second consecutive year, including two 5-star contracts and a 4.5-star contract.
Management raised full-year outlook and provided Q4 and FY2025 ranges: FY revenue $3.931B–3.946B, adjusted EBITDA $90M–98M, and Q4 revenue $995M–1.010B.